Background
Methods
Results
Global analysis
Diagnostic period | No (%) of patients |
---|---|
1990–1994 | 611 (16.7) |
1995–1999 | 673 (18.4) |
2000–2004 | 726 (19.8) |
2005–2009 | 806 (22.0) |
2010–2014 | 839 (22.9) |
Sex | |
Male | 2036 (55.7) |
Female | 1619 (44.2) |
Type of Disease | |
Acute lymphoblastic/hybrid Leukemia | 1036 (28.3) |
Acute non lymphoblastic Leukemia | 220 (6.0) |
Chronic Myeloid Leukemia | 24 (0.6) |
Non Hodgkin Lymphoma | 281 (7.6) |
Hodgkin Lymphoma | 189 (5.1) |
CNS Tumours | 500 (13.6) |
No CNS Tumours | 1405 (38.4) |
Province of residence | |
Napoli | 2059 (56.3) |
Salerno | 625 (17.0) |
Caserta | 589 (16.1) |
Avellino | 229 (6.2) |
Benevento | 153 (4.1) |
Disease | 1990–1994 | 1995–1999 | 2000–2004 | 2005–2009 | 2010–2014 |
---|---|---|---|---|---|
ALL | 210 (20.5) | 193 (18.8) | 205 (20.0) | 199 (19.4) | 217 (21.1) |
LA hybrid/undiff. | 6 (50.0) | 4 (33.3) | 1 (8.3) | 1 (8.3) | 0 |
ANLL | 39 (17.7) | 42 (19.0) | 40 (18.1) | 50 (22.7) | 49 (22.2) |
MCL | 5 (20.8) | 3 (12.5) | 3 (12.5) | 4 (16.6) | 9 (37.5) |
NHL | 52 (18.5) | 63 (22.4) | 59 (20.9) | 61 (21.7) | 46 (16.3) |
HL | 16 (8.4) | 35 (18.5) | 35 (18.5) | 41 (21.6) | 62 (32.8) |
Neuroblastoma | 75 (21.9) | 58 (16.9) | 67 (19.5) | 72 (21) | 70 (20.4) |
CNS Tumour | 31 (6.2) | 78 (15.6) | 118 (23.6) | 122 (24.4) | 151 (30.5) |
Kidney Tumour | 44 (21.7) | 45 (22.2) | 29 (14.3) | 39 (19.3) | 45 (22.2) |
Soft tissue sarcoma | 31 (14.6) | 44 (20.7) | 45 (21.2) | 56 (26.4) | 36 (16.9) |
Histiocytosis | 25 (14.8) | 27 (16.0) | 33 (19.6) | 47 (27.9) | 36 (21.4) |
GCT | 15 (14.0) | 18 (16.8) | 12 (11.2) | 29 (27.1) | 33 (30.8) |
S. Ewing/PNET | 14 (12.8) | 20 (18.3) | 22 (20.1) | 22 (20.1) | 31 (28.4) |
Retinoblastoma | 16 (20.7) | 9 (11.6) | 22 (28.5) | 20 (25.9) | 10 (12.9) |
Bone Tumour | 16 (25.3) | 12 (19.0) | 8 (12.6) | 14 (22.2) | 13 (20.6) |
Liver Tumour | 6 (13.3) | 12 (26.6) | 9 (20.0) | 8 (17.7) | 10 (22.2) |
Nasofaryngeal carcinoma | 3 (33.3) | 1 (11.1) | 2 (22.2) | 2 (22.2) | 1 (11.1) |
Adrenocortical carcinoma | 3 (27.2) | 2 (18.1) | 3 (27.2) | 0 | 3 (27.2) |
Other Tumours | 4 (6.6) | 7 (11.6) | 13 (21.6) | 19 (31.6) | 17 (28.3) |
Total | 611 (16.7) | 673 (18.4) | 726 (19.8) | 806 (22) | 839 (22.9) |
O/E ratio cases by type of cancer and period of observation
Disease | 1990–1994 | 1995–1999 | 2000–2004 | 2005–2009 | 2010–2014 | ||
---|---|---|---|---|---|---|---|
E | O | O/E | O/E | O/E | O/E | O/E | |
Leukemias | 260 | 260 | 1.0 | 0.93 | 0.95 | 0.97 | 1.0 |
Limphomas | 115 | 68 | 0.59 | 0.85 | 0.81 | 0.88 | 0.93 |
CNS tumours | 205 | 31 | 0.15 | 0.38 | 0.57 | 0.59 | 0.73* |
Solid tumours (no CNS) | 305 | 252 | 0.82 | 0.83 | 0.86 | 1.0 | 1.0 |
O/E ratio cases by province of residence at diagnosis and period of observation
Province of residence | 1990–1994 | 1995–1999 | 2000–2004 | 2005–2009 | 2010–2014 | ||
---|---|---|---|---|---|---|---|
E/5 years | O | O/E | O/E | O/E | O/E | O/E | |
Napoli | 465 | 344 | 0.73 | 0.82 | 0.90 | 0.98 | 0.96* |
Caserta | 130 | 101 | 0.77 | 0.71 | 0.83 | 0.99 | 1.2* |
Salerno | 140 | 97 | 0.69 | 0.84 | 0.85 | 0.94 | 1.1 |
Avellino | 50 | 40 | 0.80 | 1.0 | 0.80 | 1.0 | 0.90 |
Benevento | 35 | 29 | 0.82 | 0.74 | 1.0 | 0.94 | 0.77 |
Extra-regional migration by period of observation and type of disease
Disease | No patients/total (%) |
---|---|
Acute lymphoblastic/hybrid Leukemia | 143/1036 (13.8) |
Acute non lymphoblastic Leukemia | 37/220 (16.8) |
Chronic Myeloid Leukemia | 3/24 (12.5) |
Non Hodgkin Lymphoma | 73/281 (25.9) |
Hodgkin Lymphoma | 47/189 (24.8) |
Neuroblastoma | 93/342 (28.9) |
CNS Tumours | 251/500 (50.2) |
Kidney Tumours | 44/202 (21.7) |
Soft Tissue Sarcoma | 70/212 (33.0) |
Histiocytosis | 40/168 (23.8) |
Germinal Cell Tumours | 24/107 (22.4) |
S. Ewing/PNET | 57/109 (52.2) |
Retinoblastoma | 50/77 (64.9) |
Bone Tumours | 42/63 (66.6) |
Liver Tumours | 22/45 (48.8) |
Other Tumours | 27/60 (45.0) |
Total | 1029/3655 (28.1) |
Province of residence | |
Napoli | 392/2059 (19.0) |
Salerno | 266/625 (42.5) |
Caserta | 175/589 (29.7) |
Avellino | 104/229 (45.4) |
Benevento | 68/153 (44.4) |
Disease | 1990–1994 | 1995–1999 | 2000–2004 | 2005–2009 | 2010–2014 |
---|---|---|---|---|---|
ALL | 40 (18.5) | 29 (15) | 29 (14.7) | 23 (11.1) | 22 (10.1) |
ANLL | 15 (38.4) | 7 (16.6) | 3 (7.5) | 7 (14) | 6 (12.2) |
MCL | 1 (20.0) | 1 (33.3) | 1 (33.3) | 0 | 0 |
NHL | 19 (36.5) | 22 (34.9) | 18 (30.5) | 12 (19.6) | 2 (4.3) |
HL | 5 (31.2) | 8 (22.8) | 14 (40.0) | 9 (21.9) | 11 (17.7) |
Neuroblastoma | 32 (42.6) | 22 (37.9) | 17 (25.3) | 19 (26.3) | 9 (12.8) |
CNS Tumour | 25 (80.6) | 40 (51.2) | 67 (56.7) | 66 (54) | 53 (35.0) |
Kidney Tumour | 14 (31.8) | 10 (22.2) | 7 (24.1) | 7 (17.9) | 6 (13.3) |
Soft tissue sarcoma | 12 (38.7) | 10 (22.7) | 20 (44.4) | 20 (35.7) | 8 (22.2) |
Histiocytosis | 4 (16.0) | 7 (25.9) | 10 (30.3) | 10 (21.2) | 9 (25.0) |
GCT | 4 (26.6) | 3 (16.6) | 4 (33.3) | 7 (24.1) | 6 (18.1) |
S. Ewing/PNET | 9 (64.2) | 14 (70.0) | 8 (36.3) | 9 (40.9) | 17 (54.8) |
Retinoblastoma | 2 (12.5) | 3 (33.3) | 17 (77.2) | 18 (90) | 10 (100) |
Bone Tumour | 15 (93.7) | 11 (91.6) | 6 (75.0) | 7 (50) | 3 (23.0) |
Liver Tumour | 4 (66.6) | 7 (58.3) | 4 (44.4) | 4 (50) | 3 (30.0) |
Other Tumours | 5 (50.0) | 6 (60.0) | 4 (22,2) | 5 (23.8) | 7 (33.3) |
Total | 206/611 (33.7) | 200/673 (29.7) | 229/726 (31.5) | 223/806 (27.6) | 171/839 (20.3) |
Extra-regional migration by province of residence
Province of residence | 1990–1994 | 1995–1999 | 2000–2004 | 2005–2009 | 2010–2014 |
---|---|---|---|---|---|
Napoli | 85 (24.7) | 72 (18.7) | 92 (21.9) | 82 (17.8) | 61 (13.5) |
Caserta | 32 (31.6) | 31 (33.3) | 40 (37.0) | 39 (30.2) | 33 (20.8) |
Salerno | 44 (45.3) | 53 (44.9) | 56 (46.6) | 55 (41.6) | 58 (36.7) |
Avellino | 21 (52.5) | 23 (45) | 19 (47.5) | 29 (54.7) | 12 (26.6) |
Benevento | 17 (58.6) | 12 (46.1) | 18 (47.3) | 14 (42.4) | 7 (25.9) |